ENVB

Enveric Biosciences Inc

• TipRanks·04/02 13:55

  Psychedelic: Clearmind completes treatment, follow-up for CMND-100 trial

• Benzinga·04/02 12:05

  12 Health Care Stocks Moving In Thursday's Pre-Market Session

• Reuters·03/31 21:27

  Enveric Biosciences wins new US patent covering EVM301 drug candidates including EB-003

• Benzinga·03/31 12:14

  Enveric Biosciences Receives U.S. Patent For Its EVM301 Series Of Molecules

• TipRanks·03/31 12:12

  Enveric Biosciences secures new U.S. patent for its EVM301 series

• Reuters·03/31 12:07

  ENVERIC BIOSCIENCES INC - RECEIVES U.S. PATENT FOR EVM301 SERIES OF DRUG CANDIDATES ON MARCH 17

• Seeking Alpha·03/30 08:33

  Enveric Biosciences GAAP EPS of -$6.12

• Benzinga·03/27 21:52

  Enveric Biosciences Q4 EPS $(0.50) Up From $(57.96) YoY

• Dow Jones·03/27 21:45

  *Enveric Biosciences 4Q Loss/Shr $6.12 >ENVB

• Reuters·03/27 21:40

  ENVERIC BIOSCIENCES INC - Q4 LOSS PER SHARE $6.12

• Dow Jones·03/27 21:40

  Press Release: Enveric Biosciences Reports -2-

• Reuters·03/27 21:28

  Enveric Biosciences FY2025 operating loss narrows 8.91% to $8.8 million; net loss narrows 8.38% to $8.8 million

• Reuters·03/27 21:26

  Enveric Biosciences FY2025 net loss climbs 25% to $4.0 million; cash-on-hand falls to $4.7 million

• Benzinga·03/27 17:28

  'Bipartisan Senators File Bill To Support Psychedelics Research And Treatment For Veterans' - Marijuana Moment

• TipRanks·03/19 15:45

  Psychedelic: AtaiBeckley reports publication of BPL-003 study results